Published in N Engl J Med on December 28, 2006
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res (2012) 2.85
Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc (2010) 2.19
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17
Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res (2006) 1.91
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Osteoporosis in men. Endocr Rev (2008) 1.80
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol (2007) 1.75
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab (2011) 1.71
Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int (2008) 1.71
Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med (2008) 1.53
Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med (2003) 1.50
Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab (2005) 1.44
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med (2009) 1.40
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res (2010) 1.35
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol (2010) 1.34
The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab (2008) 1.29
Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res (2012) 1.28
Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res (2009) 1.13
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol (2008) 1.10
Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int (2004) 1.09
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res (2011) 1.08
Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ (2010) 1.05
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab (2012) 1.01
Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res (2011) 1.01
Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength. J Med Device (2013) 0.98
Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res (2014) 0.97
Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res (2007) 0.96
Youth: a health plan-based lifestyle intervention increases bone mineral density in adolescent girls. Arch Pediatr Adolesc Med (2006) 0.94
Once-yearly zoledronic acid in older men compared with women with recent hip fracture. J Am Geriatr Soc (2011) 0.92
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control (2010) 0.91
Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS. J Bone Miner Res (2011) 0.89
Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs). BMC Nephrol (2013) 0.89
Implications in the use of T-scores for the diagnosis of osteoporosis in men. J Clin Densitom (2002) 0.88
Smoking predicts incident fractures in elderly men: Mr OS Sweden. J Bone Miner Res (2010) 0.88
Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res (2007) 0.87
Inferior physical performance tests in 10,998 men in the MrOS study is associated with recurrent falls. Age Ageing (2012) 0.87
Inferior physical performance test results of 10,998 men in the MrOS Study is associated with high fracture risk. Age Ageing (2012) 0.86
Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res (2013) 0.86
Sex-specific effect of Pirin gene on bone mineral density in a cohort of 4000 Chinese. Bone (2009) 0.86
Weekly oral alendronic Acid in male osteoporosis. Clin Drug Investig (2004) 0.86
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial. J Clin Endocrinol Metab (2015) 0.84
Obstructive sleep apnea during rapid eye movement sleep, daytime sleepiness, and quality of life in older men in Osteoporotic Fractures in Men (MrOS) Sleep Study. J Clin Sleep Med (2013) 0.84
Association of intact parathyroid hormone levels with subsequent hip BMD loss: the Osteoporotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab (2012) 0.84
Serum insulin-like growth factor-I concentration is associated with leukocyte telomere length in a population-based cohort of elderly men. J Clin Endocrinol Metab (2009) 0.84
Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men. Clin Chim Acta (2009) 0.83
Functional polymorphisms affecting the clinically important arginine-137 residue of AVPR2 do not influence serum sodium concentration at the population level. Physiol Genomics (2013) 0.83
Objective measures of physical activity, fractures and falls: the osteoporotic fractures in men study. J Am Geriatr Soc (2013) 0.83
Serum estradiol is associated with lean mass in elderly Swedish men. Eur J Endocrinol (2010) 0.82
Periosteal remodeling at the femoral neck in nonhuman primates. J Bone Miner Res (2006) 0.82
Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab (2015) 0.82
Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. J Clin Endocrinol Metab (2007) 0.81
Vitamin D receptor 3' haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J Bone Miner Res (2007) 0.81
Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions. Ther Adv Musculoskelet Dis (2013) 0.81
The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Calcium metabolism and cardiovascular function after spaceflight. J Appl Physiol (1985) (2002) 0.81
Estimation of physical performance and measurements of habitual physical activity may capture men with high risk to fall--data from the Mr Os Sweden cohort. Arch Gerontol Geriatr (2008) 0.80
Heterozygosity for a coding SNP in COL1A2 confers a lower BMD and an increased stroke risk. Biochem Biophys Res Commun (2009) 0.80
Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg (2011) 0.79
YOUTH: decisions and challenges in designing an osteoporosis prevention intervention for teen girls. Prev Med (2004) 0.79
Osteoporosis and fractures in postmenopausal women using estrogen. Arch Intern Med (2002) 0.78
Limited clinical utility of a genetic risk score for the prediction of fracture risk in elderly subjects. J Bone Miner Res (2015) 0.78
There is in elderly men a group difference between fallers and non-fallers in physical performance tests. Age Ageing (2011) 0.77
Association of SRD5A2 variants and serum androstane-3alpha,17beta-diol glucuronide concentration in Chinese elderly men. Clin Chem (2010) 0.77
Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. J Clin Endocrinol Metab (2014) 0.77
International and ethnic variability of falls in older men. Scand J Public Health (2013) 0.76
Absence of AVPR2 copy number variation in eunatremic and dysnatremic subjects in non-Hispanic Caucasian populations. Physiol Genomics (2009) 0.75
Fracture risk and zoledronic acid in men with osteoporosis. N Engl J Med (2013) 0.75
Quality indicators for management of osteoporosis. Ann Intern Med (2002) 0.75
Creating an institutional resource for research education and career development: a novel model from Oregon Clinical and Translational Research Institute. Clin Transl Sci (2014) 0.75
The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism. J Clin Endocrinol Metab (2007) 0.75